a comparative controlled clinical trial of epsilon aminocaproic acid ( eaca ) , 36 g/day and tranexamic acid ( tea ) , 6 g/day , was undertaken to assess their effectiveness in reducing early recurrence of subarachnoid haemorrhage ( sah ) .
C0040613
tranexamic acid
C0038525
subarachnoid haemorrhage